Howard L. Elford - Search Results

Year	Number of Results
2002	3
2004	3
2005	3
2006	3
2007	1
2009	1
2010	1
2011	1
2014	1
2015	1
2017	2
2020	1
2021	1
2024	1

1

Inayat MS, Bernard AC, Gallicchio VS, Garvy BA, Elford HL, Oakley OR. Inayat MS, et al. Among authors: elford hl. Transfus Apher Sci. 2006 Feb;34(1):25-32. doi: 10.1016/j.transci.2005.09.005. Epub 2005 Dec 22. Transfus Apher Sci. 2006. PMID: 16376617 Review.

2

Didox (3,4-dihydroxybenzohydroxamic acid) reduces the vascular inflammation induced by acute intravascular hemolysis.

Silva JAF, Gotardo ÉMF, Chweih H, Miguel LI, Ferreira WA Jr, Hedlund B, Elford HL, Leonardo FC, Costa FF, Conran N. Silva JAF, et al. Among authors: elford hl. Blood Cells Mol Dis. 2020 Mar;81:102404. doi: 10.1016/j.bcmd.2020.102404. Epub 2020 Jan 11. Blood Cells Mol Dis. 2020. PMID: 31972517 No abstract available.

3

Molecular Targeting of RRM2, NF-κB, and Mutant TP53 for the Treatment of Triple-Negative Breast Cancer.

Wilson EA, Sultana N, Shah KN, Elford HL, Faridi JS. Wilson EA, et al. Among authors: elford hl. Mol Cancer Ther. 2021 Apr;20(4):655-664. doi: 10.1158/1535-7163.MCT-20-0373. Epub 2021 Feb 3. Mol Cancer Ther. 2021. PMID: 33536192

4

Didox (3,4-dihydroxybenzohydroxamic acid) suppresses IL-33-induced cytokine production in primary mouse mast cells.

Caslin HL, McLeod JJA, Spence AJ, Qayum AA, Kolawole EM, Taruselli MT, Paranjape A, Elford HL, Ryan JJ. Caslin HL, et al. Among authors: elford hl. Cell Immunol. 2017 Sep;319:10-16. doi: 10.1016/j.cellimm.2017.04.013. Epub 2017 Jul 11. Cell Immunol. 2017. PMID: 28750923 Free PMC article.

5

Targeting the Cell Cycle, RRM2 and NF-κB for the Treatment of Breast Cancers.

Sultana N, Elford HL, Faridi JS. Sultana N, et al. Among authors: elford hl. Cancers (Basel). 2024 Feb 28;16(5):975. doi: 10.3390/cancers16050975. Cancers (Basel). 2024. PMID: 38473336 Free PMC article.

6

Didox (3,4-dihydroxybenzohydroxamic acid) suppresses IgE-mediated mast cell activation through attenuation of NFκB and AP-1 transcription.

McLeod JJA, Caslin HL, Spence AJ, Kolawole EM, Qayum AA, Paranjape A, Taruselli M, Haque TT, Kiwanuka KN, Elford HL, Ryan JJ. McLeod JJA, et al. Among authors: elford hl. Cell Immunol. 2017 Dec;322:41-48. doi: 10.1016/j.cellimm.2017.09.008. Epub 2017 Sep 21. Cell Immunol. 2017. PMID: 28964543 Free PMC article.

7

The efficacy of the ribonucleotide reductase inhibitor Didox in preclinical models of AML.

Cook GJ, Caudell DL, Elford HL, Pardee TS. Cook GJ, et al. Among authors: elford hl. PLoS One. 2014 Nov 17;9(11):e112619. doi: 10.1371/journal.pone.0112619. eCollection 2014. PLoS One. 2014. PMID: 25402485 Free PMC article.

8

Targeting Ribonucleotide Reductase M2 and NF-κB Activation with Didox to Circumvent Tamoxifen Resistance in Breast Cancer.

Shah KN, Wilson EA, Malla R, Elford HL, Faridi JS. Shah KN, et al. Among authors: elford hl. Mol Cancer Ther. 2015 Nov;14(11):2411-21. doi: 10.1158/1535-7163.MCT-14-0689. Epub 2015 Sep 2. Mol Cancer Ther. 2015. PMID: 26333382

9

Synergistic cytotoxicity of the ribonucleotide reductase inhibitor didox (3,4-dihydroxy-benzohydroxamic acid) and the alkylating agent carmustine (BCNU) in 9L rat gliosarcoma cells and DAOY human medulloblastoma cells.

Horvath Z, Höchtl T, Bauer W, Fritzer-Szekeres M, Elford HL, Szekeres T, Tihan T. Horvath Z, et al. Among authors: elford hl. Cancer Chemother Pharmacol. 2004 Aug;54(2):139-45. doi: 10.1007/s00280-004-0795-0. Epub 2004 May 4. Cancer Chemother Pharmacol. 2004. PMID: 15133626

10

Combination of inhibitors of lymphocyte activation (hydroxyurea, trimidox, and didox) and reverse transcriptase (didanosine) suppresses development of murine retrovirus-induced lymphoproliferative disease.

Mayhew CN, Sumpter R, Inayat M, Cibull M, Phillips JD, Elford HL, Gallicchio VS. Mayhew CN, et al. Among authors: elford hl. Antiviral Res. 2005 Jan;65(1):13-22. doi: 10.1016/j.antiviral.2004.09.003. Antiviral Res. 2005. PMID: 15652967

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

21 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year